Skip to content

Clinical trials

Phase 2 Hepatitis C, Chronic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 2 Country / region: France Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20042
20052
20061
20073
20083
20092
20107
20116
20123
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
French National Agency for Research on AIDS and Viral Hepatitis4
ANRS, Emerging Infectious Diseases2
Boehringer Ingelheim2
Bristol-Myers Squibb2
Gilead Sciences2
GlaxoSmithKline2
Tibotec BVBA2
AbbVie (prior sponsor, Abbott)1
Debiopharm International SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic34
Hepatitis C9
HIV Infections3
Infections2
Fibrosis1
Liver Diseases1
Thrombocytopenia1
Virus Diseases1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.